文献速递免疫规划

金黄色葡萄球菌-霍乱毒素A2/B疫苗对牛乳腺炎的免疫原性

Immunogenicity of a Staphylococcus aureus-cholera toxin A2/B vaccine for bovine mastitis.
PubMed 文献 · Vaccine · 2018-05-05

本研究报道了两项牛免疫原性试验,使用纯化的IsdA与ClfA-霍乱毒素A2/B嵌合体(IsdA-CTA2/B和ClfA-CTA2/B)。奶牛在干奶期经鼻接种IsdA-CTA2/B+ClfA-CTA2/B并随访70天。试验1分三组,总浓度600或900μg,加强1或2次;试验2分两组,总浓度1200μg,加强1次。血清学应答组间显著,两试验均显示接种后抗原特异性IgG诱导;试验2第60天PBMC中CD4+ T细胞增加,IsdA和ClfA刺激诱导IL-4表达而不诱导IFN-γ或IL-17;试验2血清和乳汁抗IsdA抗体经调理吞噬试验证实功能活性。疫苗耐受良好且安全,结果支持黏膜递送CTA2/B嵌合体保护奶牛抵抗金黄色葡萄球菌性乳腺炎的潜力。

要点

  • 干奶期经鼻接种IsdA-CTA2/B与ClfA-CTA2/B嵌合体,两试验均诱导血清抗原特异性IgG。
  • 试验2第60天PBMC中CD4+ T细胞增加,抗原刺激诱导IL-4而不诱导IFN-γ或IL-17。
  • 试验2血清和乳汁抗IsdA抗体经调理吞噬试验证实功能性体外活性,疫苗耐受良好且安全。

核心结论

  • 结果支持黏膜递送CTA2/B嵌合体保护奶牛抵抗金黄色葡萄球菌性乳腺炎的潜力。

研究设计与样本

  • 两项牛免疫原性试验:奶牛在干奶期经鼻接种IsdA-CTA2/B+ClfA-CTA2/B并随访70天。
  • 试验1分三组,总浓度600或900μg,加强1或2次;试验2分两组,总浓度1200μg,加强1次。
  • 血清和乳汁体液免疫应答用ELISA检测;试验2第60天PBMC经抗原刺激后用流式细胞术检测细胞增殖,并分析细胞因子表达。

主要发现

  • 血清应答组间显著,两试验均提供接种后抗原特异性IgG诱导的证据。
  • 试验2第60天PBMC中CD4+ T细胞较接种牛增加。
  • IsdA和ClfA刺激诱导PBMC表达IL-4,但不诱导IFN-γ或IL-17。
  • 试验2血清和乳汁抗IsdA抗体经调理吞噬试验证实功能性体外活性。
  • 疫苗耐受良好且安全。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Staphylococcus aureus causes a chronic, contagious disease of the udder, or mastitis, in dairy cows. This infection is often refractory to antibiotic treatment, and has a significant economic impact on milk production worldwide. An effective vaccine to prevent S. aureus mastitis would improve animal health, reduce antibiotic dependence and inform human vaccine approaches. The iron-regulated surface determinant A (IsdA) and clumping factor A (ClfA) are conserved S. aureus extracellular-matrix adhesins and target vaccine antigens. Here we report the results of two bovine immunogenicity trials using purified IsdA and ClfA-cholera toxin A2/B chimeras (IsdA-CTA2/B and ClfA-CTA2/B). Cows were intranasally inoculated with IsdA-CTA2/B + ClfA-CTA2/B at dry off and followed for 70 days. Trial 1 utilized three groups with one or two booster doses at a total concentration of 600 or 900 μg. Trial 2 utilized two groups with one booster at a total concentration of 1200 μg. Humoral immune responses in serum and milk were examined by ELISA. Responses in serum were significant between groups and provide evidence of antigen-specific IgG induction after vaccination in both trials. Cellular proliferation was detected by flow cytometry using antigen-stimulated PBMCs from day 60 of Trial 2 and revealed an increase in CD4+ T cells from vaccinated cows. IsdA and ClfA stimulation induced IL-4 expression, but not IFN-γ or IL-17, in PBMCs from day 60 as determined by cytokine expression analysis. Opsonophagocytosis of S. aureus confirmed the functional in vitro activity of anti-IsdA antibodies from Trial 2 serum and milk. The vaccine was well tolerated and safe, and results support the potential of mucosally-delivered CTA2/B chimeras to protect cows from mastitis caused by S. aureus.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Misra N, Wines TF, Knopp CL, et al. Immunogenicity of a Staphylococcus aureus-cholera toxin A2/B vaccine for bovine mastitis. Vaccine. 2018. PMID: 29739718. doi:10.1016/j.vaccine.2018.04.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。